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Promoting transparency of research and data needs much more attentionMaking research data and data analysis more transparent
has many advantages for scientific progress [1]. It serves im-
portant objectives such as replicability, accountability, effi-
ciency, cumulation of evidence over time, and prevention
and correction of disputable data management and (un)in-
tentional misconduct. In addition, if collected data are pub-
licly available, the international research community can be
better mobilized to harvest the scientific potential of the in-
creasing number and size of data sources. However, to safe-
guard that these objectives can be achieved in the context of
valid and ethically appropriate research, various complex is-
sues need to be urgently addressed. In a Variance and Dissent
series initiated by Robert West and introduced by Kotz et al.,
consisting of a number of compact contributions (West,
Bouter, Ioannidis, Shamseer and Roberts, Goldacre and
Brown, Attwood and Munafo, Koers, Knottnerus, West),
the importance of promoting transparency and accountabil-
ity of research and of data disclosure, and related challenges
and conditions, are discussed. Also, other pertinent issues
are addressed, such as the need for concerted action of the
responsible actors involved, the importance of investing in
the education and training in good scientific practice of
young researchers, and considering ‘the end of scientific ar-
ticles as we know them’ [2]. The urgency of addressing the
issues discussed in this series is illustrated by Hopkins et al.
who evaluated current data sharing activities of the UK pub-
licly funded Clinical Trial Units (CTUs). Using a web-based
survey of directors of 45 CTUs, they found that there is sup-
port for data sharing. However, there are concerns about po-
tential misuse of data and resource implications of data
sharing activities. Further work is being done, including de-
velopment of guidance for publicly funded CTUs, to pro-
mote good practices for data sharing. Another example of
the importance of transparency is the study by Ebrahim
and co-authors. They investigated the impact of industry in-
volvement in the publication and interpretation of meta-
analyses of trials evaluating antidepressants. Based on this
review of meta-analyses, they conclude that there is a mas-
sive production of meta-analyses of antidepressants auth-
ored by or linked to the industry. These almost never
include any negative concluding statement in their abstracts
about the studied antidepressants. According to the authors
caution is needed in interpreting meta-analyses with ties to
manufacturers.
One of the preconditions for transparency and account-
ability that are already implemented is the public registrationhttp://dx.doi.org/10.1016/j.jclinepi.2016.01.007
0895-4356/ 2016 Elsevier Inc. This is an open access article under the CC BYof clinical trial protocols, that can then later be related to pub-
lished reports of trial results. To assess adherence to protocol
and the reporting of results after the introduction of the Food
and Drug Administration Amendment Act (FDAAA), Pranic
andMarusic compared protocols registered in ClinicalTrials.
gov to corresponding research publications. They found sub-
stantial discrepancies between, e.g., registered and published
outcomes, nature of statistical methods used, and in the re-
porting of adverse events. Given their results, the authors
make recommendations to facilitate the assessment of such
discrepancies, and call for immediate attention of all stake-
holders in health research. As registration not only of study
protocols of randomized trial but also of observational stud-
ies has been advocated, Boccia and collaborators investi-
gated the status of registration of observational studies.
They compared prospective cancer studies that were regis-
tered in ClinicalTrials.gov with corresponding publications.
The authors found that few observational studies have been
registered. Studies usually started before registration, and
prespecification of outcomes and statistical analysis rarely
occurred.
The importance and methodology of transparent and ap-
propriate reporting and reviewing of research was also ad-
dressed by other authors. Zhang and co-workers reviewed
the quality of published surgical meta-analyses. They con-
clude that both the reporting and the methodological qual-
ity of these meta-analyses were suboptimal, and relate this
to geographic, author and journal characteristics. The inves-
tigators encourage preregistration of meta-analyses. In an-
other review, Xue and colleagues assess the impact of the
search strategy language on systematic review results, using
risk factors for cerebral palsy as an example. They applied
the same search strategy in English versus Chinese lan-
guage looking for studies published in Chinese language.
Using English language for this purpose was shown to lead
to missing a substantial number of publications, and there-
fore to a biased review.
The problem of not harvesting potentially important
content of data sources can be reduced by providing tools
to support data collection. Information on the effect of in-
terventions on health equity is important for decision mak-
ers, but is not often assessed in systematic reviews.
Therefore, Welch and others developed an equity extension
of the Preferred Reporting Items for Systematic Reviews
Statement and Meta-Analysis (PRISMA) to support evi-
dence synthesis on equity. In an explanation and-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tension item, with examples for each item.
Also very important for decision makers e to meet their
needs for timely access to information e are rapid reviews.
Tricco et al., solicited experiences with and perceptions of
rapid reviews from stakeholders (researchers, policy mak-
ers, industry, editors, and health care providers), using an
international survey of rapid review producers and a modi-
fied Delphi technique. The investigators found that rapid re-
views have many names and approaches and some methods
seem more desirable than others. Further research, e.g., on
the development of methodological guidance and the eval-
uation of rapid review results, is recommended.
The predictive value of the U.S. AHRQ Evidence-
based Practice Center (EPC) approach to Grading of Rec-
ommendations Assessment, Development and Evaluation
(GRADE) was determined by Gartlehner et al. The quality
of evidence (QOE) of Cochrane reports graded as high
QOE, were independently graded by professional system-
atic reviewers. The authors found the predictive value of
the EPC approach to GRADE limited and discuss the im-
plications of this finding. Robinson et al. who were seek-
ing for an efficient and unbiased approach to integrate
systematic reviews with primary studies into new reviews,
report on the development of guidance to achieve this.
They present twelve recommendations prepared by EPC
methodologists, with input from literature search and
key informant interviews, and identified areas for future
research.
Alexander and co-workers did additional work on their
previous observation that the WHO classified a substantial
proportion of its recommendations as strong despite low
confidence in estimates of effect, which is inconsistent with
GRADE guidance [3,4]. They report two studies to further
explore and evaluate this observation, in which they inter-
viewed senior active GRADE methodologists who had
served on WHO panels and, respectively, interviewed panel
members who were involved in guidelines approved by
WHO. The authors make recommendations as to the role
of the GRADE methodologist, selection and additional
training of panelists, quality monitoring, and adherence to
GRADE principles. In another study evaluating the use of
GRADE, Movsisyan c.s. explored user perspectives on ap-
plying GRADE to systematic reviews of complex interven-
tions. Based on an email survey among authors of
systematic reviews, the investigators suggest that the
GRADE guidance be extended to address the specific con-
siderations for complex interventions. Regarding overviews
of reviews, in connection to a previously published Co-
chrane overview [5], Pollock and co-workers developed
an algorithm to applying GRADE levels of evidence in a
consistent and transparent approach. They applied this to
samples of reviews, with iterative refinement based on ex-
pert feedback. The authors propose that their approach
has implications for assessment of quality of evidence with-
in future evidence syntheses.In a study of meta-analyses of randomized trials, Alba
et al. compared the distribution of heterogeneity in meta-
analysis of binary and continuous outcomes. It was found
that meta-analyses evaluating continuous outcomes more
frequently reported high heterogeneity than meta-analyses
addressing binary outcomes. The authors suggest differing
standards for statistical interpretation in continuous vs. bi-
nary outcomes.
In the care for people with dementia, assessing quality of
life (Qol) is extremely important. Therefore, Dichter and
his team systematically reviewed available dementia-
specific Qol measurements, also to evaluate the quality of
linguistic validations and reliability studies of the measure-
ments. It is concluded that Qol measurements for dementia
are insufficiently linguistic validated and not well tested for
reliability. Application of international guidelines is
strongly recommended.
Seo et al developed a tool for classifying study designs
(Design Algorithm for Medical Literature on Intervention
(DAMI)), and tested this in a sample of mainly non-
randomized studies by comparing the classifications
through DAMI and by the original authors. Based on their
results, the authors conclude that DAMI could be an effec-
tive means of classifying medical literature for systematic
review of interventions.
Before introducing an intervention, it is important to as-
sess whether evidence on its effectiveness justifies its use in
practice or whether additional evidence is needed.
McKenna c.s., therefore evaluated how value of informa-
tion (VOI) analysis can inform research prioritization deci-
sions, illustrated by a case study of corticosteroid treatment
in brain trauma. It is concluded that VOI analysis can be in-
tegrated with the results of a meta-analysis to support the
assessment on whether a particular research protocol is po-
tentially worthwhile and should be prioritized.
Kappen and co-authors investigated how prediction tools
guide the decision-making process of physicians. They
applied a mixed methods approach using interviews and a
survey among physicians participating in a cluster-
randomized trial studying the impact of presenting
predicted risk of postoperative nausea and vomiting
(PONV) on anti-emetic prescription and PONVas outcomes.
It was found that combining probabilistic model information
with clinical experience may be difficult, but adding recom-
mendations to predicted risks may improve the uptake of the
model.
As in monitoring long term cancer survival timely dis-
closure of progress remains a challenge, Brenner and
Jansen introduced and evaluated the ‘boomerang method’.
They describe this method and compare it with established
methods in deriving up-to-date estimations of 10-year sur-
vival using a U.S. database. According to the authors, the
boomerang method can substantially improve up-to-
dateness of estimates in times of ongoing improvement in
prognosis. In another study on estimating survival, in this
case in cystic fibrosis patients using the Canadian cystic
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methods (various statistical techniques, in/exclusion crite-
ria, and missing data management) on the predicted median
survival age. Given their findings, the investigators make
recommendations to help reduce bias and to improve trans-
parency in reporting survival estimates. Kaplan-Meier
(KM) analyses are frequently used to measure outcome risk
over time, but overestimate risk whenever competing events
are present. Therefore, van Walraven and Hawken e using
simulated survival data sets e derived and validated a mod-
el that predicted true outcome risk based on the biased KM
risk, accounting for the presence of competing risks.
There is ongoing progress in facilitating large scale data
collection in health research. The Million Veteran Program
(MVP), an observational cohort study and mega-biobank of
which Gaziano and co-workers describe the design and
conduct, enables the combined collection of questionnaire,
electronic, and genomic an other laboratory data. Almost
400,000 veterans have now been enrolled in the program,
to which several ongoing projects are linked. The MVP is
designed to promote the integration of genetic testing in
health care delivery and to contribute to the development
of ‘precision medicine’. As improving the identification
of cases is crucial for optimizing cohort studies, English
and his group derived and validated a comprehensive meth-
od to screen hospital admissions for primary subarachnoid
hemorrhage (SAH), by retrospectively applying diagnostic
criteria in previously created registries. It was concluded
that the developed method accurately identifies primary
SAH cases within an extensive sampling frame. To collect
data on patterns of chronic pain over time, structured daily
text messages from patients may be helpful. This was eval-
uated by Burstr€om et al in a cohort study of low back pain
among workers. According to the authors, the use of text
messages is a simple method of in-depth data collection
when studying human responses that fluctuate on a daily
basis.
To improve measurement precision in cancer patients,
within the conceptual framework of the EORTC (European
Organisation for Research and Treatment of Cancer) Qual-
ity of Life questionnaire (QLQ-C30), Petersen et al devel-
oped and evaluated an item bank for computerized
Adapative Testing (CAT) of emotional functioning (EF).
Based on literature search and input from experts and pa-
tients, they established an EF item bank of 24 items and re-
port that the new measure allows for more precise and
flexible measurement of emotional functioning.
Saldanha and his team applied social network analysis to
understand outcome co-occurrence patterns in Cochranesystematic reviews dealing with HIV/AIDS, to identify out-
comes central to the network of outcomes in this field. The
most central and most frequent outcomes differed within
subgroups by type of HIV/AIDS intervention (i.e., clinical
management, biomedical prevention, behavioral preven-
tion, and health services). The authors recommend social
network analysis methods as a novel application that com-
plements traditional frequency consensus for developing
core outcome sets.
In connection to a previously published paper [6],
Sch€urmann & Wieseler and Ciani & Taylor discuss how
to appropriately validate surrogate endpoints for overall
survival in colorectal cancer. Sheeder and Seale briefly re-
port on a novel (low-tech, low-cost, tamper-resistant) ran-
dom allocation process for multistudy clinic setting use.
Watine criticizes the title of a previously published editorial
[7] and discusses the difference between GRADING and
grading. Finally, Chen explores the concepts self-rated
health and comparative health, and relates these to data
from the Medicare Health Outcome Survey.
J. Andre Knottnerus
Peter Tugwell
E-mail address: anneke.germeraad@maastrichtuniversity.nl
(J.A. Knottnerus)References
[1] Institute of Medicine. Sharing clinical trial data. Maximizing bene-
fits, minimizing risks. Washington DC: The National Academies
Press; 2015.
[2] West R. The end of scientific articles as we know them? J Clin Epi-
demiol 2016;70:276.
[3] Alexander PE, Bero L, Montori VM, Brito JP, Stoltzfus R,
Djulbegovic B, et al. World Health Organization recommendations
are often strong based on low confidence in effect estimates. J Clin
Epidemiol 2014;67:629e34.
[4] Alexander PE, Brito JP, Neuman I, Gionfriddo MR, Bero L,
Djulbegovic B, et al. World Health Organization strong recommenda-
tions strong based on low quality evidence (study quality) are fre-
quent and often inconsistent with GRADE guidance. J Clin
Epidemiol 2014;. http://dx.doi.org/10.1016/j.jclinepi.2014.10.011.
[Epub ahead of print].
[5] Pollock A, Farmer SE, Brady MC, Langhorne P, Mead GE,
Mehrholz J, et al. Interventions for improving upper limb function
after stroke. Cochrane Database Syst Rev 2014;CD010820.
[6] Ciani O, Buyse M, Garside R, Peters J, Saad ED, Stein K, et al. Meta-
analyses of randomized controlled trials show suboptimal validity of
surrogate outcomes for overall survival in advanced colorectal cancer.
J Clin Epidemiol 2015;68:833e42.
[7] Tugwell P, Knottnerus JA. When does a good practice statement not
justify an Evidence Based Guideline? J Clin Epidemiol 2015;
68:477e9.
